The Priority Review

Clinical trials Brief

Sanofi registers Phase 3 study of Hexaxim versus Pentaxim in Chinese infants

The study, first posted on ClinicalTrials.gov on November 17, 2026, plans to enroll 720 healthy Chinese infants to compare the safety and immunogenicity of Hexaxim with Pentaxim plus a monovalent Hep B vaccine. It plans to start on December 28, 2026, with primary completion by April 27, 2028.

Primary source

ClinicalTrials.gov registry record, November 17, 2026

Study of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants.

Read the source: Study of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants. clinicaltrials.gov

Machine-summarized from the source above; not independently reported. How we use automation